ArticleMolecular cancer therapeutics2012
Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.
Ling Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it